Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd.
Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-In-Human (FIH), Single Ascending Dose (SAD) Study and Multiple Ascending Dose (MAD) Study of SP-101 Injection | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Phase 1 | 2026-01-12 | NCT07334249 |